Oct. 15, 2009 (Business Wire) -- To support healthcare organizations in making the appropriate technology decisions to maximize federal stimulus dollar opportunity, Eclipsys Corporation®, (NASDAQ:ECLP), The Outcomes Company®, today announced the multiple superior outcomes its client organizations are achieving today. With a client base that leads the industry in adoption of computerized physician order entry (CPOE), outperforms peers in composite performance across all Centers for Medicare and Medicaid Services (CMS) Quality Measures and clinical information systems that dominate the Magnet Recognition Program® hospitals, Eclipsys offers an industry-differentiating ability to support healthcare providers in meeting the expected “meaningful use” objectives of the American Recovery and Reinvestment Act (ARRA). In addition, the company’s analytics technology provides a solid foundation to meet the expected more stringent and outcomes-focused ARRA requirements in 2013 and 2015.

A Client Base Ranked No. 1 in Meeting Composite CMS Quality Measures; Dominates Magnet Hospitals

In conducting a competitive analysis study of CMS Core Measures performance, data identified Eclipsys clients as ranking No. 1 in composite performance across all CMS Quality Measures. The study, which was based on publicly available data from HIMSS Analytics and the U.S. Department of Health and Human Services Hospital Compare site, also identified that Eclipsys clients ranked No. 1 in adherence to surgery CMS criteria, while statistically tying in adherence to heart failure, acute myocardial infarction (AMI) and pneumonia.

According to Jay Deady, Eclipsys executive vice president of Client Solutions, Eclipsys clients’ superior quality outcomes are a factor of the advanced clinical decision support and embedded complex algorithms built into the company’s CPOE solution, which leverage more than 30 years of experience to transcend fundamental computerized order entry. “Proactive, advanced clinical decision support is going to be a critical success factor in meeting ARRA ‘meaningful use’ requirements,” said Deady. “The fact that our client base today is comprised of higher-performing organizations is a clear demonstration of what sets apart Eclipsys in helping healthcare organizations improve patient health status and outcomes, the fundamental goal behind this government act. With hundreds of healthcare organizations seeking a new clinical information system platform, we expect our proven track record and strong positioning to support us in achieving expanded market share.”

Industry CPOE Adoption Leadership

A key provision of ARRA is that healthcare organizations must drive the use of information technology to improve patient health status — not just demonstrate its existence or specific functionality. According to the KLAS CPOE Digest 2009: Meaningful Use and Physician Adoption report, deep adoption is pivotal to the overarching success of an electronic medical record (EMR) implementation. The same KLAS report concludes that Eclipsys leads the industry in total physicians live on CPOE and percentage of its client base using the system. Eclipsys also continues to have the highest physician satisfaction from clients who use its system, and on average, highly customizable ordering capabilities allow a physician to order faster than any other CPOE solution on the market.